These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38742407)

  • 1. Signal Propagation in the ATPase Domain of
    Kamsri B; Kamsri P; Punkvang A; Chimprasit A; Saparpakorn P; Hannongbua S; Spencer J; Oliveira ASF; Mulholland AJ; Pungpo P
    Biochemistry; 2024 Jun; 63(11):1493-1504. PubMed ID: 38742407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The acidic C-terminal tail of the GyrA subunit moderates the DNA supercoiling activity of Bacillus subtilis gyrase.
    Lanz MA; Farhat M; Klostermeier D
    J Biol Chem; 2014 May; 289(18):12275-85. PubMed ID: 24563461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overall Structures of Mycobacterium tuberculosis DNA Gyrase Reveal the Role of a Corynebacteriales GyrB-Specific Insert in ATPase Activity.
    Petrella S; Capton E; Raynal B; Giffard C; Thureau A; Bonneté F; Alzari PM; Aubry A; Mayer C
    Structure; 2019 Apr; 27(4):579-589.e5. PubMed ID: 30744994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycobacterium tuberculosis DNA gyrase ATPase domain structures suggest a dissociative mechanism that explains how ATP hydrolysis is coupled to domain motion.
    Agrawal A; Roué M; Spitzfaden C; Petrella S; Aubry A; Hann M; Bax B; Mayer C
    Biochem J; 2013 Dec; 456(2):263-73. PubMed ID: 24015710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-Based Virtual Screening for Discovery of Indole Derivatives as Potent DNA Gyrase ATPase Inhibitors Active against
    Pakamwong B; Thongdee P; Kamsri B; Phusi N; Taveepanich S; Chayajarus K; Kamsri P; Punkvang A; Hannongbua S; Sangswan J; Suttisintong K; Sureram S; Kittakoop P; Hongmanee P; Santanirand P; Leanpolchareanchai J; Spencer J; Mulholland AJ; Pungpo P
    J Chem Inf Model; 2024 Aug; 64(15):5991-6002. PubMed ID: 38993154
    [No Abstract]   [Full Text] [Related]  

  • 6. Functional interactions between gyrase subunits are optimized in a species-specific manner.
    Weidlich D; Klostermeier D
    J Biol Chem; 2020 Feb; 295(8):2299-2312. PubMed ID: 31953321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The key DNA-binding residues in the C-terminal domain of Mycobacterium tuberculosis DNA gyrase A subunit (GyrA).
    Huang YY; Deng JY; Gu J; Zhang ZP; Maxwell A; Bi LJ; Chen YY; Zhou YF; Yu ZN; Zhang XE
    Nucleic Acids Res; 2006; 34(19):5650-9. PubMed ID: 17038336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A domain insertion in Escherichia coli GyrB adopts a novel fold that plays a critical role in gyrase function.
    Schoeffler AJ; May AP; Berger JM
    Nucleic Acids Res; 2010 Nov; 38(21):7830-44. PubMed ID: 20675723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenesis in the alpha3alpha4 GyrA helix and in the Toprim domain of GyrB refines the contribution of Mycobacterium tuberculosis DNA gyrase to intrinsic resistance to quinolones.
    Matrat S; Aubry A; Mayer C; Jarlier V; Cambau E
    Antimicrob Agents Chemother; 2008 Aug; 52(8):2909-14. PubMed ID: 18426901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico designing of domain B selective gyrase inhibitors for effective treatment of resistant tuberculosis.
    Kashyap A; Singh PK; Silakari O
    Tuberculosis (Edinb); 2018 Sep; 112():83-88. PubMed ID: 30205973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for the role of DNA strand passage in the mechanism of action of microcin B17 on DNA gyrase.
    Pierrat OA; Maxwell A
    Biochemistry; 2005 Mar; 44(11):4204-15. PubMed ID: 15766248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding and Hydrolysis of a Single ATP Is Sufficient for N-Gate Closure and DNA Supercoiling by Gyrase.
    Hartmann S; Gubaev A; Klostermeier D
    J Mol Biol; 2017 Nov; 429(23):3717-3729. PubMed ID: 29032205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacterium tuberculosis DNA gyrase as a target for drug discovery.
    Mdluli K; Ma Z
    Infect Disord Drug Targets; 2007 Jun; 7(2):159-68. PubMed ID: 17970226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the E540V amino acid substitution in GyrB of Mycobacterium tuberculosis on quinolone resistance.
    Kim H; Nakajima C; Yokoyama K; Rahim Z; Kim YU; Oguri H; Suzuki Y
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3661-7. PubMed ID: 21646485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the conformational changes of the ATP binding site of gyrase B from Escherichia coli complexed with different established inhibitors by using molecular dynamics simulation: protein-ligand interactions in the light of the alanine scanning and free energy decomposition methods.
    Saíz-Urra L; Cabrera MA; Froeyen M
    J Mol Graph Model; 2011 Feb; 29(5):726-39. PubMed ID: 21216167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of the N-terminal Gyrase B fragment in complex with ADP⋅Pi reveals rigid-body motion induced by ATP hydrolysis.
    Stanger FV; Dehio C; Schirmer T
    PLoS One; 2014; 9(9):e107289. PubMed ID: 25202966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and development of ATPase inhibitors of DNA gyrase as antibacterial agents.
    Oblak M; Kotnik M; Solmajer T
    Curr Med Chem; 2007; 14(19):2033-47. PubMed ID: 17691945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active-site residues of Escherichia coli DNA gyrase required in coupling ATP hydrolysis to DNA supercoiling and amino acid substitutions leading to novobiocin resistance.
    Gross CH; Parsons JD; Grossman TH; Charifson PS; Bellon S; Jernee J; Dwyer M; Chambers SP; Markland W; Botfield M; Raybuck SA
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1037-46. PubMed ID: 12604539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification, crystallization and preliminary X-ray crystallographic studies of the Mycobacterium tuberculosis DNA gyrase ATPase domain.
    Roué M; Agrawal A; Volker C; Mossakowska D; Mayer C; Bax BD
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Jun; 69(Pt 6):679-82. PubMed ID: 23722853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assays, surrogates, and alternative technologies for a TB lead identification program targeting DNA gyrase ATPase.
    Humnabadkar V; Madhavapeddi P; Basavarajappa H; Sheikh MG; Rane R; Basu R; Verma P; Sundaram A; Mukherjee K; de Sousa SM
    J Biomol Screen; 2015 Feb; 20(2):265-74. PubMed ID: 25300873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.